202 related articles for article (PubMed ID: 34272876)
61. Multimodality Treatment of Pediatric Esthesioneuroblastoma.
Venkatramani R; Pan H; Furman WL; Marron JM; Haduong J; Friedrich-Medina P; Mahajan A; Bavle A; Wu H; Chintagumpala M
Pediatr Blood Cancer; 2016 Mar; 63(3):465-70. PubMed ID: 26514449
[TBL] [Abstract][Full Text] [Related]
62. The impact of multidisciplinary approaches on the outcomes of olfactory neuroblastoma treated with postoperative radiotherapy.
Tsutsumi Y; Omura K; Kijima Y; Kobayashi M; Fukasawa N; Takeda T; Ebihara T; Aoki S; Otori N; Kojima H; Aoki M
Cancer Med; 2024 Mar; 13(5):e6943. PubMed ID: 38497548
[TBL] [Abstract][Full Text] [Related]
63. Esthesioneuroblastoma: updating histologic grading as it relates to prognosis.
Gallagher KK; Spector ME; Pepper JP; McKean EL; Marentette LJ; McHugh JB
Ann Otol Rhinol Laryngol; 2014 May; 123(5):353-8. PubMed ID: 24668054
[TBL] [Abstract][Full Text] [Related]
64. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
65. Long-term oncological outcome after endoscopic surgery for olfactory esthesioneuroblastoma.
De Bonnecaze G; Chaput B; Al Hawat A; Filleron T; Vairel B; Serrano E; Vergez S
Acta Otolaryngol; 2014 Dec; 134(12):1259-64. PubMed ID: 25399885
[TBL] [Abstract][Full Text] [Related]
66. Esthesioneuroblastoma: the impact of treatment modality.
Chao KS; Kaplan C; Simpson JR; Haughey B; Spector GJ; Sessions DG; Arquette M
Head Neck; 2001 Sep; 23(9):749-57. PubMed ID: 11505485
[TBL] [Abstract][Full Text] [Related]
67. Volumetric analysis of olfactory neuroblastoma skull base laterality and implications on neck disease.
Marinelli JP; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Lees KA; Kaczor MW; Janus JR
Laryngoscope; 2018 Apr; 128(4):864-870. PubMed ID: 28833165
[TBL] [Abstract][Full Text] [Related]
68. Retained role of surgery for olfactory neuroblastoma.
Smee RI; Broadley K; Williams JR; Meagher NS; Bridger GP
Head Neck; 2011 Oct; 33(10):1486-92. PubMed ID: 21928422
[TBL] [Abstract][Full Text] [Related]
69. Endonasal endoscopic resection of olfactory neuroblastoma: an 11-year experience.
Gallia GL; Asemota AO; Blitz AM; Lane AP; Koch W; Reh DD; Ishii M
J Neurosurg; 2018 Aug; 131(1):238-244. PubMed ID: 30074458
[TBL] [Abstract][Full Text] [Related]
70. Esthesioneuroblastoma with distant metastases: Systematic review & meta-analysis.
Marinelli JP; Janus JR; Van Gompel JJ; Link MJ; Foote RL; Lohse CM; Price KA; Chintakuntlawar AV
Head Neck; 2018 Oct; 40(10):2295-2303. PubMed ID: 29756250
[TBL] [Abstract][Full Text] [Related]
71. Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol.
Rimmer J; Lund VJ; Beale T; Wei WI; Howard D
Laryngoscope; 2014 Jul; 124(7):1542-9. PubMed ID: 24347437
[TBL] [Abstract][Full Text] [Related]
72. The developing management of esthesioneuroblastoma: a single institution experience.
Bäck L; Oinas M; Pietarinen-Runtti P; Saarilahti K; Vuola J; Saat R; Öhman J; Haglund C; Niemelä M; Leivo I; Hagström J; Mäkitie AA
Eur Arch Otorhinolaryngol; 2012 Jan; 269(1):213-21. PubMed ID: 21404006
[TBL] [Abstract][Full Text] [Related]
73. Esthesioneuroblastoma. Long-term outcome and patterns of failure--the University of Virginia experience.
Eden BV; Debo RF; Larner JM; Kelly MD; Levine PA; Stewart FM; Cantrell RW; Constable WC
Cancer; 1994 May; 73(10):2556-62. PubMed ID: 8174053
[TBL] [Abstract][Full Text] [Related]
74. [Neoadjuvant chemotherapy in the treatment of locally advanced olfactory neuroblastoma in 25 cases].
Sun Y; Zhang SR; Wang MJ; Huang Q; Cui SJ; Yang BT; Qiu E; Li C; Zhou B
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 May; 58(5):425-430. PubMed ID: 37100753
[No Abstract] [Full Text] [Related]
75. Esthesioneuroblastoma: A Patterns-of-Care and Outcomes Analysis of the National Cancer Database.
Orton A; Boothe D; Evans D; Lloyd S; Monroe MM; Jensen R; Shrieve DC; Hitchcock YJ
Neurosurgery; 2018 Nov; 83(5):940-947. PubMed ID: 29481629
[TBL] [Abstract][Full Text] [Related]
76. Esthesioneuroblastoma: A Comprehensive Review of Diagnosis, Management, and Current Treatment Options.
Fiani B; Quadri SA; Cathel A; Farooqui M; Ramachandran A; Siddiqi I; Ghanchi H; Zafar A; Berman BW; Siddiqi J
World Neurosurg; 2019 Jun; 126():194-211. PubMed ID: 30862589
[TBL] [Abstract][Full Text] [Related]
77. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000.
Theilgaard SA; Buchwald C; Ingeholm P; Kornum Larsen S; Eriksen JG; Sand Hansen H
Acta Otolaryngol; 2003 Apr; 123(3):433-9. PubMed ID: 12737303
[TBL] [Abstract][Full Text] [Related]
78. Malignant tumors of the nasal cavity and paranasal sinuses.
Katz TS; Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Villaret DB
Head Neck; 2002 Sep; 24(9):821-9. PubMed ID: 12211046
[TBL] [Abstract][Full Text] [Related]
79. Long-term control of olfactory neuroblastoma in a dog treated with surgery and radiation therapy.
Gumpel E; Moore AS; Simpson DJ; Hoffmann KL; Taylor DP
Aust Vet J; 2017 Jul; 95(7):227-231. PubMed ID: 28653386
[TBL] [Abstract][Full Text] [Related]
80. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
